Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:06:58 EDT Sat 27 Apr 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:PRTA
- PROTHENA CORP PLC -
http://www.prothena.com
01:06:58 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
PRTA
- Q
0.1
19.87
·
27.08
0.1
20.87
+0.31
1.5
370.0
7,449
4,531
20.72
21.18
20.3401
79.65 19.65
17:05:33
Apr 15
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Up
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 4531
More trades...
Time ET
Ex
Price
Change
Volume
17:05:33
Q
20.87
0.31
799
16:20:00
Q
20.87
0.31
567
16:13:45
Q
20.87
0.31
15
16:01:54
Q
20.87
0.31
445
16:01:32
Q
20.87
0.31
9
16:01:11
Q
20.87
0.31
1,005
16:00:07
Q
20.87
0.31
1,739
16:00:07
Q
20.87
0.31
29
16:00:07
Q
20.87
0.31
229
16:00:02
Q
20.87
0.31
332
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-04-15 16:05
U:PRTA
News Release
200
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
2024-03-05 16:05
U:PRTA
News Release
200
Prothena to Participate in Upcoming Healthcare Conferences
2024-02-15 16:05
U:PRTA
News Release
200
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
2024-02-08 16:05
U:PRTA
News Release
200
Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
2024-01-08 08:30
U:PRTA
News Release
200
Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs
2023-11-02 16:05
U:PRTA
News Release
200
Prothena Reports Third Quarter 2023 Financial Results and Business Highlights
2023-10-26 16:05
U:PRTA
News Release
200
Prothena to Report Third Quarter 2023 Financial Results on November 2
2023-08-31 16:05
U:PRTA
News Release
200
Prothena to Participate in Upcoming Healthcare Conferences
2023-08-03 16:05
U:PRTA
News Release
200
Prothena Reports Second Quarter 2023 Financial Results and Business Highlights
2023-07-27 16:05
U:PRTA
News Release
200
Prothena to Report Second Quarter 2023 Financial Results on August 3
2023-07-17 08:35
U:PRTA
News Release
200
Prothena Presents New Research in the Treatment of Alzheimer ¢ € ™s Disease at Alzheimer ¢ € ™s Association International Conference ‚ ® 2023 (AAIC ‚ ®)
2023-07-11 16:05
U:PRTA
News Release
200
Prothena to Present New Data from Alzheimer ¢ € ™s Disease Programs at Alzheimer ¢ € ™s Association International Conference ‚ ® 2023 (AAIC ‚ ®)
2023-07-10 16:10
U:PRTA
News Release
200
Prothena Announces Bristol Myers Squibb Opt-in for Worldwide Rights of PRX005, a Novel Anti-MTBR-Tau Antibody
2023-06-27 16:05
U:PRTA
News Release
200
Prothena Announces Phase 3 VITAL Clinical Trial Results Published in Blood Showing Survival Benefit in Patients with Mayo Stage IV AL Amyloidosis Treated with Birtamimab
2023-06-02 16:05
U:PRTA
News Release
200
Prothena to Participate in Jefferies 2023 Healthcare Conference
2023-05-16 16:05
U:PRTA
News Release
200
Prothena Announces Appointment of Billy Dunn, M.D., to its Board of Directors
2023-05-04 16:05
U:PRTA
News Release
200
Prothena Reports First Quarter 2023 Financial Results and Business Highlights